Focus Taiwan App

Scientist expects biomed research to remain focused on antibodies

08/28/2017 10:13 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Aug. 28 (CNA) Antibody and small molecule drugs and big data applications will remain at the center of biomedical research in the future, according to Andrew Wang (王惠鈞), president-elect of the International Union of Biochemistry and Molecular Biology (IUBMB).

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.